Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2008

01-02-2008 | Original Paper

Clinical Outcomes of Patients with Liver Cirrhosis Who Underwent Curative Surgery for Gastric Cancer: A Retrospective Multi-center Study

Authors: Hyun Joo Jang, Jung Han Kim, Hun Ho Song, Kyung Hee Woo, Mi Kim, Sea Hyub Kae, Jin Lee, Ji Wong Cho, Jung Hun Kang, Soon Il Lee, Soo Jung Gong, Jung Ae Lee, Dae Young Zang

Published in: Digestive Diseases and Sciences | Issue 2/2008

Login to get access

Abstract

We investigated early postoperative morbidity, mortality, and long-term outcomes in patients with liver cirrhosis (LC) who had undergone curative surgery for gastric cancer. The medical records of patients with LC who had undergone radical gastrectomy for gastric adenocarcinoma between January 1996 and September 2006 were retrospectively reviewed. A total of 57 patients were enrolled in this study. Forty-six patients (81%) were classified into Child’s class A. In 22 patients (39%) postoperative complications developed, the most common being ascites (23%), followed by wound infection and hepatic encephalopathy. Postoperative ascites occurred more frequently in patients with Child’s class B or C than in those with class A (63.6% vs 13%, = 0.001). Massive ascites developed in 4 patients, 3 of whom had Child’s class B and underwent D2 lymph node (LN) dissection, and 1 of whom had Child’s class C and a D1 LN dissection. Postoperative mortality occurred in 5 patients (9%), with a significantly higher mortality rate for patients with Child’s class B or C than for those with class A (27.2% vs 4.3%, = 0.045). With a median follow-up of 32 months, the estimated 5-year survival rate for all patients was 54%. Regardless of the tumor depth, overall survival was longer for patients with Child’s class A than for those with Child’s class B or C. These results demonstrated that radical gastrectomy with extended LN dissection is feasible in patients with compensated LC. For patients with moderate to severe hepatic dysfunction, however, D1 or less extensive LN dissection may be the more reasonable surgical procedure.
Literature
1.
go back to reference Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, Ohrr HC, Ahn DH, Ferlay J, Parkin DM, Oh DK, Park JG (2002) Cancer incidence in Korea. Cancer Res Treatment 34:405–408 Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, Ohrr HC, Ahn DH, Ferlay J, Parkin DM, Oh DK, Park JG (2002) Cancer incidence in Korea. Cancer Res Treatment 34:405–408
2.
go back to reference Lee JH, Kim J, Cheong JH, Hyung WJ, Choi SH, Noh SH (2005) Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11:4623–4627PubMed Lee JH, Kim J, Cheong JH, Hyung WJ, Choi SH, Noh SH (2005) Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11:4623–4627PubMed
3.
go back to reference Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236–242PubMedCrossRef Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236–242PubMedCrossRef
4.
go back to reference Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R (1993) Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol 25:473–476PubMed Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R (1993) Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol 25:473–476PubMed
5.
go back to reference Zullo A, Romiti A, Tomao S, Hassan C, Rinaldi V, Giustini M, Morini S, Taggi F (2003) Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev 12:179–182PubMedCrossRef Zullo A, Romiti A, Tomao S, Hassan C, Rinaldi V, Giustini M, Morini S, Taggi F (2003) Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev 12:179–182PubMedCrossRef
6.
go back to reference Liu CL, Fan ST, Lo CM, Wong Y, Ng IO, Lam CM, Poon RT, Wong J (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239:194–201PubMedCrossRef Liu CL, Fan ST, Lo CM, Wong Y, Ng IO, Lam CM, Poon RT, Wong J (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239:194–201PubMedCrossRef
7.
go back to reference Mansour A, Watson W, Shayani V, Pickleman J (1997) Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122:730–735PubMedCrossRef Mansour A, Watson W, Shayani V, Pickleman J (1997) Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122:730–735PubMedCrossRef
8.
go back to reference Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N (1997) Surgery for gastric cancer in patients with liver cirrhosis. Surg Today 27:17–21PubMedCrossRef Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N (1997) Surgery for gastric cancer in patients with liver cirrhosis. Surg Today 27:17–21PubMedCrossRef
9.
go back to reference Ryu KW, Lee JH, Kim YW, Park JW, Bae JM (2005) Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg 29:653–656PubMedCrossRef Ryu KW, Lee JH, Kim YW, Park JW, Bae JM (2005) Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg 29:653–656PubMedCrossRef
10.
go back to reference Dumont AE, Mulholland JH (1962) Alteration in thoracic duct lymph flow in hepatic cirrhosis. Significance in portal hypertension. Ann Surg 156:668–677PubMedCrossRef Dumont AE, Mulholland JH (1962) Alteration in thoracic duct lymph flow in hepatic cirrhosis. Significance in portal hypertension. Ann Surg 156:668–677PubMedCrossRef
11.
go back to reference Kumagai K (1998) Intractable ascites following surgery for gastric carcinoma. Surg 15:236–240 Kumagai K (1998) Intractable ascites following surgery for gastric carcinoma. Surg 15:236–240
12.
go back to reference Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018PubMedCrossRef Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018PubMedCrossRef
13.
go back to reference Takeda J, Hashimoto K, Tanaka T, Koufuji K, Kakegawa T (1992) Review of operative indication and prognosis in gastric cancer with hepatic cirrhosis. Hepatogastroenterology 39:433–436PubMed Takeda J, Hashimoto K, Tanaka T, Koufuji K, Kakegawa T (1992) Review of operative indication and prognosis in gastric cancer with hepatic cirrhosis. Hepatogastroenterology 39:433–436PubMed
Metadata
Title
Clinical Outcomes of Patients with Liver Cirrhosis Who Underwent Curative Surgery for Gastric Cancer: A Retrospective Multi-center Study
Authors
Hyun Joo Jang
Jung Han Kim
Hun Ho Song
Kyung Hee Woo
Mi Kim
Sea Hyub Kae
Jin Lee
Ji Wong Cho
Jung Hun Kang
Soon Il Lee
Soo Jung Gong
Jung Ae Lee
Dae Young Zang
Publication date
01-02-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9884-3

Other articles of this Issue 2/2008

Digestive Diseases and Sciences 2/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.